School of Medicine
Showing 8,241-8,250 of 13,025 Results
-
Justin Norden, MD, MBA, MPhil
Affiliate, School of Medicine - Biomedical Ethics
BioDr. Justin Norden is an Adjunct Professor at Stanford Medicine in the Department of Biomedical Informatics Research. He teaches courses on digital health and AI in Medicine. His research focuses on AI in healthcare, digital health, and care system transformation.
Additionally, Dr. Norden is a Partner at GSR Ventures where he focuses on early-stage investments in digital health and AI/ML in healthcare. Prior to GSR Ventures, Dr. Norden was founder and CEO of Trustworthy AI which was acquired by Waymo (Google Self-Driving). He worked on the healthcare team at Apple, co-founded Indicator (an NLP based platform for biopharma decision making), and helped start the Stanford Center for Digital Health.
Dr. Norden received an MD from Stanford University School of Medicine, where he served as student body president. An MBA from the Stanford Graduate School of Business, where he served as president of the healthcare club. An M.Phil in Computational Biology with distinction from the University of Cambridge, and a BA in Computer Science with distinction from Carleton College.
Finally, he is a professional athlete for the Oakland Spiders (ultimate frisbee) - holding the team all-time records for assists and completions. He is a 3x World Champion, 1x professional champion, former Team USA Captain (U24), and D1 University National Champion. -
Amir Norouzpour
Basic Life Research Scientist, Ophthalmology Research/Clinical Trials
Current Role at StanfordResearch Scientist
-
Robert L Norris Jr
Professor of Emergency Medicine at the Stanford University Medical Center, Emeritus
Current Research and Scholarly InterestsEnvironmental toxinology, with special emphasis on envenomations (particularly snake venom poisoning; Airway management techniques; Tactical medicine
-
Jeffrey Norton, MD
Robert L. and Mary Ellenburg Professor of Surgery, Emeritus
Current Research and Scholarly InterestsInterleukin-12 is a Th1 cytokine. It is important in the cell mediated immune response. We are investigating its role as an anti-tumor cytokine to augment the immune response against cancer. We are planning a human trial.
